Therapeutic Potential of Kappa-Opioids Against Cocaine - 1

Completed

Conditions studied: Cocaine-Related Disorders

In brief

The purpose of this study is to characterize the effects of enadoline compared to hydromorphone and butorphanol.

Key facts

Study ID

NCT00000323

Run by

National Institute on Drug Abuse (NIDA)

People needed

10

Starts

1996-07-01

Expected to finish

1998-12-01

Last updated by the study team

2017-01-12

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• opiate experienced, healthy

You may not qualify if…

• physical dependence on opioids, barbiturates or alcohol

Where it is running

• Johns Hopkins University (BPRU) Bayview Campus — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.